The interactions between the patient and physician are among the most sensitive in our lives, since they concern the most private area of our existence.
- A trusting, honest and open discussion between patients and caregivers is the most important basis for dealing optimally with the disease situation.
- My task is to leave no stone unturned to get the clearest possible picture of the patient’s situation. This is an important prerequisite for the selection of the most appropriate treatment to ensure an optimal disease course.
- The patient is the central focus, with his/her conceptions and needs as the basis for the appropriate treatment steps with the aim of reestablishing and optimizing emotional and physical well-being.
Established Treatment Methods
- Targeted therapies
- Immunotherapy and immunomodulators
- Hormone therapy
- Regional tumor therapy
- Supportive therapy
- Cytokine therapy
- Stem cell transplantation
- Cellular cancer therapy
Current Treatment Trends
- We are in the midst of a scientific revolution that has led to clearer understanding of how cancer develops. Traditional treatment methods are thrown overboard and new, successful and better tolerated therapies are introduced.
- Targeted therapy and several forms of immune therapy are increasingly being used for treatment of cancer, but chemotherapy is still an essential component of cancer treatment.
- Chemotherapy is still the standard treatment in many tumors, but is increasingly being replaced by ‘targeted therapy', immunotherapy and direct genetic modification of the immune system.
- These new treatment approaches are not associated with the conventional side effects of chemotherapy, but they also often have their own specific side effects.
- Surgical measures still are an important mainstay of cancer treatment, with current attempts aiming to minimize surgical intervention.
- Radiation therapy will be more precisely focused on the tumor, thereby reducing the risk of damaging healthy tissue.
- More and more cancer drugs will be available as oral medicines while the use of intravenous chemotherapy will decline.